StonvexLoading…
StonvexStonvexStonvexCore line items from CNTB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $64.00K | $26.03M | $0.00 |
Operating Income | $-58.07M | $-22.45M | $-69.06M |
Net Income | $-55.48M | $-15.63M | $-62.11M |
EPS (Diluted) | $-1.00 | $-0.28 | $-1.13 |
Total Assets | $56.08M | $101.28M | $127.38M |
Total Liabilities | $14.10M | $9.12M | $25.88M |
Cash & Equivalents | $38.34M | $78.23M | $105.66M |
Free Cash Flow OCF − CapEx | $-51.64M | $-24.36M | $-47.82M |
Shares Outstanding | 56.44M | 55.35M | 55.10M |